Tislelizumab,Sorafenib
BeiGene,bayer,Novartis
['novartis']
novartis continues to do work for patients with unresectable #hepatocellularcarcinoma. join us at #esmo22 to see our latest data.
Committed to providing medical & scientific disease education information to healthcare professionals. See our community guidelines: https://t.co/pj8hG1sQAu